MENUMENU
  • Covid Clear
  • About Us
        • About Us

          An industry leading services provider in viral challenge studies and laboratory services supporting product development for customers developing antivirals, vaccines and respiratory therapeutics.

          • More about hVIVO
        • Overview
        • Executive Leadership Team
        • Scientific Papers / Abstracts
        • Quality Commitment
        • Ethics & Compliance
        • FluCamp
        • Human Challenge Programme
        • Challenge Agent Manufacturing
        • PrEP Biopharm Ltd
        • Imutex Ltd.
  • Services
        • Human challenge full-service solution
        • human challenge full service solution

          Industry leading provider of viral challenge studies

          • See Our Solution
        • hVIVO Challenge Models
          • Influenza
          • RSV
          • HRV
          • Asthma
          • COPD
          • Cough
        • Laboratory Services
          • Virology
          • Immunology
          • Biomarkers
  • News, Media & Events
        • News, Media & Events

          A source for the latest press releases, scientific publications and other media as well as details of investor and scientific events that we attend and host across the world.

        • News & Media
        • Media Coverage
        • Company News
        • Media Press Kit
        • Videos
        • Events
        • img

          LATEST PRESS RELEASE

          21.01.21 Article published in Drug Discovery Today
        • UPCOMING EVENTS

          Shares Investor Webinar

          Wednesday 3rd February

  • Volunteers
  • Careers
  • Contact Us

Categories for influenza

Recap on the hVIVO oral presentation at Flu 2016, San Francisco, October 2016

Scientific paper 112 – Differential evolution of peripheral cytokine levels in symptomatic and asymptomatic responses to experimental influenza virus challenge

hVIVO’s Dr Rob Lambkin-Williams making oral presentation at Human Antibodies & Hybridomas (“HAH 2016”), Belfast, November 2016

hVIVO’s Dr Anthony Gilbert to speak at Flu 2016, San Francisco at the end of October

Missed Options IX in Chicago ? Not too late to view the four hVIVO poster presentations

hVIVO making significant number of poster presentations at influenza conference, Options IX, along with exhibition presence, Chicago USA, August 2016

Whether you’re a potential customer, job seeker, health professional or an investor, you can find the best way to contact us from the list below.

Contact Us
  • Terms & Conditions
  • Careers
  • Sitemap
© 2021 Copyright hVIVO Services Limited. All rights reserved. hVIVO Services Limited (“hVIVO”) is registered in England and Wales with registration number 02326557 and registered office at Queen Mary BioEnterprises Innovation Centre, 42 New Road, London, E1 2AX, UK.
Privacy Policy | Cookie Policy